Login / Signup

Diagnostic Accuracy of Immunohistochemistry in Detecting MGMT Methylation Status in Patients with Glioma.

Nita SaharaRachmat Andi HartantoNaomi YoshuantariKusumo DananjoyoIrianiwati WidodoChetana Prakash Deshmukh
Published in: Asian Pacific journal of cancer prevention : APJCP (2021)
IHC examination can be used to detect MGMT methylation status of glioma patients in limited resources setting, where PCR technique is not available.
Keyphrases
  • end stage renal disease
  • dna methylation
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • genome wide
  • peritoneal dialysis
  • prognostic factors
  • gene expression
  • patient reported outcomes